The Sumitomo Mitsui Trust Holdings Inc. reached $47,339,000 position of Henry Schein Inc. (HSIC)

The Sumitomo Mitsui Trust Holdings Inc. reached $47,339,000 position  of Henry Schein Inc. (HSIC)

Sumitomo Mitsui Trust Holdings Inc. decreased its stake in Henry Schein Inc. (NASDAQ:HSIC) by 4.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 267,756 shares of the company’s stock after selling 12,811 shares during the period. Sumitomo Mitsui Trust Holdings Inc.’s holdings in Henry Schein were worth $47,339,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. UBS Asset Management Americas Inc. raised its stake in shares of Henry Schein by 64.1% in the first quarter. UBS Asset Management Americas Inc. now owns 515,425 shares of the company’s stock worth $88,977,000 after buying an additional 201,375 shares during the period. Bank of Montreal Can purchased a new stake in shares of Henry Schein during the second quarter worth approximately $32,344,000. Henderson Group PLC raised its stake in shares of Henry Schein by 74.7% in the second quarter. Henderson Group PLC now owns 400,128 shares of the company’s stock worth $70,741,000 after buying an additional 171,078 shares during the period. Artemis Investment Management LLP raised its stake in shares of Henry Schein by 97.5% in the second quarter. Artemis Investment Management LLP now owns 111,236 shares of the company’s stock worth $19,666,000 after buying an additional 54,920 shares during the period. Finally, Geode Capital Management LLC raised its stake in shares of Henry Schein by 4.1% in the first quarter. Geode Capital Management LLC now owns 772,565 shares of the company’s stock worth $133,135,000 after buying an additional 30,593 shares during the period. Hedge funds and other institutional investors own 92.03% of the company’s stock.

Henry Schein Inc. (NASDAQ:HSIC) traded down 0.10% during trading on Monday, hitting $153.21. The stock had a trading volume of 599,709 shares. The firm has a market capitalization of $12.53 billion, a PE ratio of 25.95 and a beta of 1.05. Henry Schein Inc. has a 1-year low of $142.64 and a 1-year high of $183.00. The firm has a 50 day moving average price of $162.17 and a 200-day moving average price of $170.06.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Thursday, August 4th. The company reported $1.64 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.63 by $0.01. The company had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.85 billion. Henry Schein had a net margin of 4.42% and a return on equity of 17.84%. The business’s revenue was up 9.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.46 EPS. On average, equities research analysts expect that Henry Schein Inc. will post $6.57 EPS for the current year.

A number of analysts have recently commented on HSIC shares. Zacks Investment Research lowered Henry Schein from a “hold” rating to a “sell” rating in a report on Monday, August 8th. Bank of America Corp. assumed coverage on Henry Schein in a research report on Monday, September 12th. They issued a “buy” rating and a $185.00 target price on the stock. Robert W. Baird reaffirmed an “outperform” rating and issued a $176.00 target price (up previously from $175.00) on shares of Henry Schein in a research report on Tuesday, October 4th. Finally, Goldman Sachs Group Inc. raised Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 target price on the stock in a research report on Tuesday, October 11th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $159.50.

In other news, Director Paul Brons sold 3,381 shares of the stock in a transaction dated Monday, August 29th. The shares were sold at an average price of $164.03, for a total transaction of $554,585.43. Following the transaction, the director now owns 13,715 shares of the company’s stock, valued at approximately $2,249,671.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.27% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.

Related posts

Leave a Comment